Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Discover the latest content that has just been published on Research Tree
Saipem maintained the upward momentum in the top-line and margins as the management has been reassuring the market for the past year following the capital increase. H1 revenues reached €5.3bn, up by 28% yoy. EBITDA recorded a more impressive increase at 68% and was on track to achieve the company’s FY guidance. The working capital outflow of €121m due to the backlog review weighed on the half-year operating cash flow, which was still strong enough to cover the capex.
Companies: Saipem (SPM:BIT)Saipem S.p.A. (SPM:MIL)
AlphaValue
Net income at breakeven was a welcome development after a long sequence of negative results since Q3 FY19. Annual margins will remain in line with the Q1 (7.4%) as the onshore EPC business will lag. Working capital management positively contributed to cash flow thanks to the sound cash profile of projects. There are no plans to raise new debt currently due to the inauspicious market environment as the available cash covers the debt maturities until FY25 and new facilities worth €860m provide a g
A booming upstream investment market boosted Saipem’s order intake and revenues by a respective 86% and 53% in FY22. The diluting backlog review, higher net financial expenses, higher taxes paid on revenues, a significant negative contribution from equity investments and the closure of the Russian activities all led to a negative net result, preventing Saipem from enjoying a net profit in an auspicious market environment.
After a successful capital increase thanks to which Saipem reduced its net debt massively, the recovery gained momentum in Q3 with a healthy order intake and the timely execution of projects. With a 9M adjusted EBITDA of €536m already surpassing the previous guidance, Saipem is now guiding for €550m for the year-end.
No negative surprise this quarter, the results coming in slightly above consensus with an adj. EBITDA of €148m and an adj. net result of €-32m. Revenues increased by 49% qoq in the E&C Offshore division to €1.2bn, while the EBITDA margin improved by 30bps to 8.1% (EBITDA at €101m). The 2022-2025 targets were confirmed (with FY22 adj. EBITDA of €500m).
Companies: Saipem S.p.A. (0RPI:LON)Saipem S.p.A. (SPM:MIL)
One month after the update on the recap and FY21 release, the Q1 results were without incident (on the financials), which is a positive given the current context. The adjusted EBITDA stood at €145m, against guidance of >€500m for FY22, i.e. a good start to the year for Saipem. The management confirmed the guidance and the company has received the advances from Eni and CDP (€650m) as well as the liquidity facility from banks (€850m).
Reassuring update showing no further deterioration in the backlog, an outlook looking more realistic than the previous one, and a robust financing package supported by the existing shareholders. While we don’t know yet what will be the dilution, this package is enough to put the company in a solid financial position and allows Saipem to focus on project execution and delivery of the backlog. The negative is on cash generation, which will become meaningful only in 2025.
The stock is down 25% as the company revises its backlog and initiates discussions with lenders and main shareholders for financing support. Margins are deteriorating in E&C as the company struggles with the pandemic, increasing raw material costs, and supply chains. Not a good look for the CEO, who presented his strategy and guidance only three months ago.
The results were below consensus with revenues of €1.9bn and adjusted EBITDA of €-25m, and H2 guidance is lowered to revenues of c. €4.5bn, while net debt is guided for a €500m increase by end of FY22. Given the company’s recent issues, the short-term concerns logically take priority over the 2025 plan. It seems that Saipem will have to reassure first before being valued on what management says it will deliver by 2025.
Another difficult quarter with an EBITDA of €-266m, way below consensus. Saipem continues to suffer in its core divisions from delays in project execution, the suspension of Mozambique LNG and operational issues in offshore wind. This prompts management to discuss with its lenders as it will breach its financial covenants at the end of the year. A small positive is the updated outlook for revenues of €7.7-8.2bn, higher than our estimate of €6.4bn.
Double-whammy for the contractor, which posted results below consensus and is left with many unknowns in Mozambique. The pandemic continues to impact project execution with delays and rescheduling. In Mozambique, Saipem is in close cooperation with Total and is not in a position to evaluate its impacts on its financials for 2021. The contract is worth €4bn in Saipem’s backlog with €1.4bn for the rest of the year.
Q4 revenues improve 15% qoq, which only met the timid outlook provided in Q3, and margins are declining further as the company is having issues on a renewable project. Management commented that “2021 is certainly not yet a back-to-normal year” and did not provide any meaningful guidance, only that net debt is expected to rise with higher capex. The only bright spot is on the order intake with the award from Qatargas.
The group showed revenues improving by €200m qoq, with the activity picking up only in onshore E&C. The soft guidance was reiterated, the management expecting H2 to be substantially in line with H1, which we believed was too conservative at the time. With Q3 results now in, this no longer seems to be the case. On the positive side, the group has renegotiated its financial covenants.
The hit was harder than expected with postponements of contracts and slower activity. While management expects a gradual recovery in H2 and a “more normal 2021”, a cost savings programme has been launched to offset part of the postponements this year.
Companies: Saipem S.p.A.
The mere €15m of orders intake in drilling activities highlights the poor state of the services industry. Understandably, management has withdrawn its guidance and could not provide an updated one on the “continuing highly unstable environment”. However, the press release also mentioned “good future business opportunities”. If this is a way to spark enthusiasm, we believe it was unnecessary as it adds confusion.
Research Tree provides access to ongoing research coverage, media content and regulatory news on Saipem S.p.A.. We currently have 4 research reports from 3 professional analysts.
Companies: Judges Scientific plc
Shore Capital
eEnergy’s H1 update confirms that trading remains in line with expectations with momentum building at the start H2’24. As previously reported, H1 started slowly as a result of weak market conditions and balance sheet constraints, which were resolved by the sale of the Energy Management (EM) division in Q1. Encouragingly, market conditions have improved and full year revenue guidance has been maintained at £25-26m. We make no changes to our underlying forecasts or fair value of 13p/ share. In o
Companies: eEnergy Group PLC
Equity Development
Invinity hosted their inaugural capital markets day at their manufacturing facilities in Scotland. The day marked the official opening of the company’s new 26,000 sq. ft assembly facility in Motherwell and included a tour of their current Bathgate facility near Edinburgh, consisting of a deep dive into their technology, manufacturing and R&D focus areas. Our key takeaway from the event is that Invinity are well placed to take advantage of accelerating demand for long duration electricity storage
Companies: Invinity Energy Systems PLC
Longspur Clean Energy
AUCTUS PUBLICATIONS ________________________________________ ADX Energy (ADX AU)C; target of A$0.75 per share: Diversified and high impact newsflow over the balance of 2024 – ADX has confirmed a very busy programme of activity from September. The overall unrisked value of the programme is ~A$1.70 per share, which represents 17x the current share price. In early September, ADX will drill the Anshof-2A side track. The well is expected to intersect thick Eocene reservoirs similar to that encountere
Companies: EQNR ENI GPRK ADX KAR WDS GALP REP REP EOG PANR TRIN ZPHR CHAR TTE ENI EQNR VAR ATOM GALP TCF
Auctus Advisors
discoverIE’s Q125 trading update confirmed that underlying earnings expectations for FY25 are unchanged. While the Q125 revenue decline reflects the lower bookings environment in previous quarters, book-to-bill was above one and bookings increased organically year-on-year despite ongoing destocking by customers in the industrial market. Robust gross margins and a well-controlled cost base support the company’s 13.5% target operating margin for FY25 and we maintain our forecasts.
Companies: discoverIE Group PLC
Edison
SigmaRoc now holds the number one or two position in a duopoly market structure within the European lime and limestone market. This makes it the only UK listed peer with this level of exposure to a fundamentally important sector exhibiting significant organic growth opportunities and strong pricing power. SigmaRoc is now capable of generating revenue in excess of £1bn with EBITDA margins towards 25%, backed by a high-quality asset base and long-term contracts with OEMs. Investors have been patie
Companies: SigmaRoc Plc
Zeus Capital
Strix has released a trading update for the six months to June (H1 24) confirming that trading remains in line with expectations (Zeus FY24e PBT: £24.2m). Cash generation in the period has been strong and follows an exceptional performance in FY23, where management converted over 100% of EBITDA into operating cash flow. Net debt is now comfortably below 2.0x and Zeus forecast it to reach 1.7x by year end. Leverage risk has materially reduced in the last six to eight months and gearing could reac
Companies: Strix Group PLC
We initiate coverage of Van Elle, the UK’s largest ground engineering and foundations specialist. Van Elle is at the ‘front end’ of the construction process and, in our view, will be among the first companies to benefit from national priorities of housebuilding and investment in creaking water and energy transmission sectors, all of which Van Elle has targeted for growth. These sectors should be supported by the Labour government, which has pledged 1.5 million new homes and aims to speed up plan
Companies: Van Elle Holdings Plc
Progressive Equity Research
Companies: PEB PEN ELCO EMR HSP CNSL STX HERC
Cavendish
Joiners: No joiners today. Leavers: Medica Group plc has left the Premium Segment of the Main Market. What’s cooking in the IPO kitchen?** Blackpoint Biotech plc, a medical cannabinoids company established to fulfil gaps in the medical cannabis market by creating products that provide fast onset of action and accurate dosing, intends to join intends to join the Access Segment of the AQSE Growth Market. Expected Admission 20 July 2023. Metals One Plc, a company focusing on acquiring natural resou
Companies: TNTAF CRL ITM VAST CMX RENX MAFL HE1
Hybridan
Forterra has indicated that recent industry-wide data showing declines in brick deliveries as a result of lower housebuilding volumes is likely to impact its expected FY23 volumes, leading the group to moderate current year guidance for revenue and PBT. Forterra has responded by outlining further steps to align production with demand, but notes that heightened political focus on increasing housing supply reinforces its long-term confidence.
Companies: Forterra Plc
Companies: BILN IGP RBN SBTX